Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma.
作者信息
Sparkman Jordan, Hernaez Ruben, El-Serag Hashem B
机构信息
Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Section of Gastroenterology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
出版信息
Transl Gastroenterol Hepatol. 2018 Nov 26;3:97. doi: 10.21037/tgh.2018.11.05. eCollection 2018.
Abstract
摘要
相似文献
1
Traditional Chinese Medicine to the rescue of allopathic medicine in the co-adjuvant treatment of hepatocellular carcinoma.中医辅助西医共同治疗肝细胞癌。
Transl Gastroenterol Hepatol. 2018 Nov 26;3:97. doi: 10.21037/tgh.2018.11.05. eCollection 2018.
2
Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma.辅助中药治疗对肝癌患者长期生存的影响。
Phytomedicine. 2019 Sep;62:152930. doi: 10.1016/j.phymed.2019.152930. Epub 2019 May 11.
3
ESTABLISHMENT AND EVALUATION OF ORTHOTOPIC HEPATOCELLULAR CARCINOMA AND DRUG-INDUCED HEPATOCELLULAR CARCINOMA IN MICE WITH SPLEEN-DEFICIENCY SYNDROME IN TRADITIONAL CHINESE MEDICINE.中医脾虚证小鼠原位肝细胞癌及药物性肝细胞癌的建立与评价
Afr J Tradit Complement Altern Med. 2016 Nov 23;14(1):165-173. doi: 10.21010/ajtcam.v14i1.18. eCollection 2017.
4
Complementary and alternative medicine (CAM): a review for the primary care physician.补充与替代医学（CAM）：初级保健医生的综述
Hawaii Med J. 1999 Feb;58(2):9-19.
5
The use and safety of non-allopathic Indian medicines.非对抗疗法的印度药物的使用与安全性。
Drug Saf. 2002;25(14):1005-19. doi: 10.2165/00002018-200225140-00003.
6
7
A Case of Recurrent Hepatocellular Carcinoma Acquiring Complete Remission of Target Lesion With Treatment With Traditional Chinese Medicine.一例复发性肝细胞癌经中医治疗后靶病灶完全缓解的病例
Integr Cancer Ther. 2017 Dec;16(4):597-604. doi: 10.1177/1534735416660617. Epub 2016 Jul 21.
8
[Research progress on anti-hepatocellular carcinoma mechanism of active ingredients of traditional Chinese medicine].[中药活性成分抗肝细胞癌机制的研究进展]
Zhongguo Zhong Yao Za Zhi. 2020 Jul;45(14):3395-3406. doi: 10.19540/j.cnki.cjcmm.20200429.601.
9
Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.中药来源的化合物在癌症治疗中的应用：以肝细胞癌为例。
J Ethnopharmacol. 2013 Oct 7;149(3):601-12. doi: 10.1016/j.jep.2013.07.030. Epub 2013 Aug 1.
10
Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.中草药在肝细胞癌中的预防和治疗作用
J Chin Med Assoc. 2015 Mar;78(3):139-44. doi: 10.1016/j.jcma.2014.09.003. Epub 2014 Oct 25.
引用本文的文献
1
Huaier granule improves liver inflammation and fibrosis and prevents recurrence in hepatitis B virus related hepatocellular carcinoma.槐耳颗粒可改善乙型肝炎病毒相关性肝细胞癌的肝脏炎症和纤维化，并预防复发。
Transl Cancer Res. 2024 Feb 29;13(2):569-578. doi: 10.21037/tcr-23-1347. Epub 2024 Feb 20.
2
Transcatheter arterial chemoembolization combined with Hippo/YAP inhibition significantly improve the survival of rats with transplanted hepatocellular carcinoma.经导管动脉化疗栓塞联合 Hippo/YAP 抑制显著改善移植性肝癌大鼠的生存。
Lipids Health Dis. 2021 Jul 25;20(1):74. doi: 10.1186/s12944-021-01486-w.
3
Cardiovascular disease due to novel coronavirus and the search for investigational therapies.新型冠状病毒引起的心血管疾病与探索性治疗方法。
J Vasc Surg. 2021 Jan;73(1):13-17. doi: 10.1016/j.jvs.2020.04.503. Epub 2020 May 17.
本文引用的文献
1
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肝细胞癌风险。
Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.
2
Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial.槐耳颗粒对肝癌根治性切除术后复发的影响：一项多中心、随机临床试验。
Gut. 2018 Nov;67(11):2006-2016. doi: 10.1136/gutjnl-2018-315983. Epub 2018 May 25.
3
How we approach it: treatment options for hepatocellular carcinoma.我们如何应对：肝细胞癌的治疗选择
Am J Gastroenterol. 2018 Jun;113(6):791-794. doi: 10.1038/s41395-018-0008-9. Epub 2018 May 1.
4
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.欧洲肝脏研究学会临床实践指南：肝细胞癌的管理
J Hepatol. 2018 Jul;69(1):182-236. doi: 10.1016/j.jhep.2018.03.019. Epub 2018 Apr 5.
5
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.乐伐替尼与索拉非尼用于不可切除肝细胞癌患者一线治疗的比较：一项随机、III 期非劣效性试验。
Lancet. 2018 Mar 24;391(10126):1163-1173. doi: 10.1016/S0140-6736(18)30207-1.
6
AASLD guidelines for the treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌治疗指南。
Hepatology. 2018 Jan;67(1):358-380. doi: 10.1002/hep.29086.
7
Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.2000年至2012年美国50个州肝细胞癌的发病率
Gastroenterology. 2017 Mar;152(4):812-820.e5. doi: 10.1053/j.gastro.2016.11.020. Epub 2016 Nov 23.
8
Impact of sustained viral response postcurative therapy of hepatitis C-related hepatocellular carcinoma: a systematic review and meta-analysis.丙型肝炎相关肝细胞癌根治性治疗后持续病毒学应答的影响：一项系统评价和荟萃分析。
Int J Cancer. 2017 Mar 1;140(5):1042-1049. doi: 10.1002/ijc.30521. Epub 2016 Dec 19.
9
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial.索拉非尼辅助治疗肝细胞癌切除术后或消融后（STORM）：一项 3 期、随机、双盲、安慰剂对照试验。
Lancet Oncol. 2015 Oct;16(13):1344-54. doi: 10.1016/S1470-2045(15)00198-9. Epub 2015 Sep 8.
10
The anticancer effect of Huaier (Review).槐耳的抗癌作用（综述）
Oncol Rep. 2015 Jul;34(1):12-21. doi: 10.3892/or.2015.3950. Epub 2015 May 5.
Zotero 插件